E11.3539 Type 2 diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment not involving the macula, unspecified eye

Name of the Condition

• Common Name: Type 2 Diabetes with Proliferative Diabetic Retinopathy and Traction Retinal Detachment (Non-Macula, Unspecified Eye)
• Medical Term: Type 2 diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment not involving the macula, unspecified eye

Summary

This condition is a severe complication of type 2 diabetes characterized by the growth of abnormal new blood vessels in the retina (proliferative diabetic retinopathy) and subsequent traction retinal detachment that does not affect the macula, affecting an unspecified eye. It arises from prolonged high blood sugar levels damaging retinal blood vessels, potentially leading to vision impairment or blindness if untreated. The combination of proliferative changes and traction detachment indicates advanced retinal damage requiring prompt management.

Causes

High blood sugar levels over time damage the small blood vessels in the retina, triggering the growth of fragile, abnormal blood vessels. These vessels can form scar tissue that pulls on the retina, leading to traction retinal detachment. This process is driven by diabetes-related vascular changes and metabolic imbalances, which disrupt normal retinal function and structure.

Risk Factors

• Poorly controlled blood glucose levels.
• Long duration of diabetes.
• Hypertension and high cholesterol.
• Smoking and obesity.
• Family history of diabetic eye disease.

Symptoms

• Blurred or distorted vision.
• Floaters or spots in the visual field.
• Reduced peripheral vision.
• Sudden vision loss (if detachment progresses).
• Difficulty seeing in low light.

Diagnosis

Diagnosis involves a comprehensive eye examination, including dilated retinal imaging (e.g., fundus photography, optical coherence tomography) to assess retinal blood vessel growth and detachment. Fluorescein angiography may be used to visualize abnormal vessels. Visual acuity tests and retinal mapping help determine the extent of damage and whether the macula is involved.

Treatment Options

• Intravitreal anti-VEGF injections to reduce abnormal blood vessel growth.
• Laser photocoagulation to seal leaking vessels and prevent further proliferation.
• Vitrectomy surgery to remove scar tissue and reattach the retina if detachment is severe.
• Strict glycemic control and management of comorbidities (e.g., hypertension) to slow disease progression.

Prognosis and Follow-Up

Prognosis depends on the timeliness of treatment and the extent of retinal damage. Early intervention can preserve vision, but advanced cases may result in permanent vision loss. Regular follow-up with an ophthalmologist is critical to monitor for recurrence or progression, typically every 3–6 months.

Complications

• Permanent vision loss or blindness.
• Recurrent retinal detachment.
• Glaucoma due to abnormal blood vessel growth in the eye.
• Cataracts, which may develop or worsen.

Lifestyle & Prevention

• Maintain tight blood glucose control through diet, exercise, and medication.
• Regular eye exams (at least annually) to detect early retinal changes.
• Manage blood pressure and cholesterol levels.
• Avoid smoking and limit alcohol intake.
• Adopt a heart-healthy diet rich in fruits, vegetables, and whole grains.

When to Seek Professional Help

Seek immediate medical attention if you experience sudden vision changes, increased floaters, or flashes of light, as these may indicate retinal detachment. Routine eye exams are essential for early detection, even in the absence of symptoms.

Tips for Medical Coders

Document the eye laterality (right, left, or unspecified) and confirm the absence of macular involvement to support accurate coding. Ensure clinical notes specify proliferative diabetic retinopathy with traction retinal detachment not involving the macula and the affected eye (if known) to align with the code’s requirements.